David Pyott, president and CEO of Allergan, adds the position of chairman, replacing Herbert Boyer who continues as vice chairman. The company posted a net profit of $52.1 million in the 1st quarter, up from $43.5 million in the year-ago period. Sales grew by 5.3 percent to $396.1 million, with ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.